Yi‐Fang Tsai

737 total citations
47 papers, 473 citations indexed

About

Yi‐Fang Tsai is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yi‐Fang Tsai has authored 47 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 18 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Yi‐Fang Tsai's work include HER2/EGFR in Cancer Research (13 papers), Cancer Cells and Metastasis (8 papers) and Cancer Genomics and Diagnostics (8 papers). Yi‐Fang Tsai is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Cancer Cells and Metastasis (8 papers) and Cancer Genomics and Diagnostics (8 papers). Yi‐Fang Tsai collaborates with scholars based in Taiwan and United States. Yi‐Fang Tsai's co-authors include Ling‐Ming Tseng, Jen‐Hwey Chiu, Chih‐Yi Hsu, Chun‐Yu Liu, Jir‐You Wang, Chu‐Wen Yang, Pei‐Ju Lien, Ta‐Chung Chao, Yi‐Ming Shyr and Chi‐Cheng Huang and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Cancer Research.

In The Last Decade

Yi‐Fang Tsai

44 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi‐Fang Tsai Taiwan	13	219	173	123	94	42	47	473
Zhaoying Yang China	15	320 1.5×	132 0.8×	247 2.0×	70 0.7×	41 1.0×	42	598
Liping Yang China	11	248 1.1×	213 1.2×	137 1.1×	89 0.9×	102 2.4×	21	578
Ramon Mohanlal United States	11	157 0.7×	226 1.3×	37 0.3×	68 0.7×	41 1.0×	49	539
Daniel D. VonHoff United States	10	366 1.7×	205 1.2×	58 0.5×	89 0.9×	26 0.6×	13	654
Xi Cheng China	12	168 0.8×	157 0.9×	105 0.9×	67 0.7×	78 1.9×	30	492
Caroline Chang United States	9	164 0.7×	129 0.7×	79 0.6×	127 1.4×	76 1.8×	14	469
Liangyu Bie China	14	283 1.3×	163 0.9×	219 1.8×	124 1.3×	66 1.6×	29	567
Gabriel Olmedilla Spain	12	237 1.1×	125 0.7×	132 1.1×	239 2.5×	53 1.3×	17	556
Tatsuhiko Shigeto Japan	12	265 1.2×	77 0.4×	122 1.0×	76 0.8×	21 0.5×	24	474

Countries citing papers authored by Yi‐Fang Tsai

Since Specialization

Citations

This map shows the geographic impact of Yi‐Fang Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Fang Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Fang Tsai more than expected).

Fields of papers citing papers by Yi‐Fang Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Fang Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Fang Tsai. The network helps show where Yi‐Fang Tsai may publish in the future.

Co-authorship network of co-authors of Yi‐Fang Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Fang Tsai. A scholar is included among the top collaborators of Yi‐Fang Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Fang Tsai. Yi‐Fang Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsai, Yi‐Fang, Chi‐Cheng Huang, Chih‐Yi Hsu, et al.. (2024). Genomic Alterations of Tumors in HER2-Low Breast Cancers. International Journal of Molecular Sciences. 25(2). 1318–1318. 5 indexed citations

Lai, Jiun‐I, Ting-Hao Kuo, Mei‐Hsuan Lee, et al.. (2023). Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The Oncologist. 29(4). e455–e466. 7 indexed citations

Kuo, Ting-Hao, Ta‐Chung Chao, Chun‐Yu Liu, et al.. (2023). Abstract P4-01-31: High Incidence of Palbociclib Related Neutropenia in Asian Patients Associated with Genetic Polymorphisms. Cancer Research. 83(5_Supplement). P4–1. 1 indexed citations

Huang, Chi‐Cheng, Yi‐Chen Yeh, Hsiang‐Ling Ho, et al.. (2023). Comprehensive genomic profiling of Taiwanese patients with breast cancer using a novel targeted panel: Preliminary analyses from a prospective triple-negative cohort.. Journal of Clinical Oncology. 41(16_suppl). e12553–e12553.

Tsai, Yi‐Fang, et al.. (2023). Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases. Breast Cancer Research and Treatment. 201(3). 547–560. 2 indexed citations

Wang, Jir‐You, et al.. (2022). Relieving patent-eligibility barriers in biotech with a preparation or treatment method. Nature Biotechnology. 40(5). 651–653. 2 indexed citations

Huang, Chi‐Cheng, Yi‐Fang Tsai, Chun‐Yu Liu, et al.. (2022). Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Annals of Surgical Oncology. 29(6). 3578–3590. 8 indexed citations

Huang, Chi‐Cheng, Yi‐Fang Tsai, Chunyu Liu, et al.. (2021). Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC Cancer. 21(1). 199–199. 13 indexed citations

Tsai, Yi‐Fang, Chi‐Cheng Huang, Pei‐Ju Lien, et al.. (2021). Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital. Journal of the Chinese Medical Association. 85(1). 88–94. 4 indexed citations

10.

Huang, Yu-Hsiang, Pei‐Yi Chu, Ji‐Lin Chen, et al.. (2021). Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. Scientific Reports. 11(1). 12171–12171. 20 indexed citations

11.

Tsai, Yi‐Fang, Chi‐Cheng Huang, Chih‐Yi Hsu, et al.. (2021). Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis. Cancer Immunology Immunotherapy. 70(8). 2339–2351. 24 indexed citations

12.

Tseng, Ling‐Ming, et al.. (2021). Developing a Web-Based Shared Decision-Making Tool for Fertility Preservation Among Reproductive-Age Women With Breast Cancer: An Action Research Approach. Journal of Medical Internet Research. 23(3). e24926–e24926. 10 indexed citations

13.

Liu, Chunyu, Chi‐Cheng Huang, Yi‐Fang Tsai, et al.. (2021). VGH-TAYLOR: Comprehensive Precision Medicine Study Protocol on the Heterogeneity of Taiwanese Breast Cancer Patients. Future Oncology. 17(31). 4057–4069. 8 indexed citations

14.

Chiu, Jen‐Hwey, Ling‐Ming Tseng, Tzu‐Ting Huang, et al.. (2020). MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation. Scientific Reports. 10(1). 8060–8060. 7 indexed citations

15.

Chen, Po‐Ming, Pei‐Yi Chu, Shiao-Lin Tung, et al.. (2017). Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up. Human Pathology. 66. 93–100. 8 indexed citations

16.

Chiu, Jen‐Hwey, Jir‐You Wang, Chih‐Yi Hsu, et al.. (2017). Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers. Journal of Translational Medicine. 15(1). 97–97. 18 indexed citations

17.

Wang, Liang‐Jen, Chih‐Ching Wu, Sheng-Yu Lee, & Yi‐Fang Tsai. (2014). Salivary Neurosteroid Levels and Behavioural Profiles of Children with Attention-Deficit/Hyperactivity Disorder During Six Months of Methylphenidate Treatment. Journal of Child and Adolescent Psychopharmacology. 24(6). 336–340. 6 indexed citations

18.

Yang, Chu‐Wen, Jir‐You Wang, Yi‐Fang Tsai, et al.. (2013). Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 29 indexed citations

19.

Tseng, Ling‐Ming, Pen‐Hui Yin, Chu‐Wen Yang, et al.. (2011). Somatic mutations of the mitochondrial genome in human breast cancers. Genes Chromosomes and Cancer. 50(10). 800–811. 38 indexed citations

20.

Kuo, Ying‐Ju, Donald Ming‐Tak Ho, Yi‐Fang Tsai, & Chih‐Yi Hsu. (2010). Invasive Ductal Carcinoma Arising in Phyllodes Tumor With Isolated Tumor Cells in Sentinel Lymph Node. Journal of the Chinese Medical Association. 73(11). 602–604. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact